These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26987614)

  • 21. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9.
    Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
    Hofer MJ; Li W; Lim SL; Campbell IL
    J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine-Tuning of Type I Interferon Response by STAT3.
    Tsai MH; Pai LM; Lee CK
    Front Immunol; 2019; 10():1448. PubMed ID: 31293595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.
    Rengachari S; Groiss S; Devos JM; Caron E; Grandvaux N; Panne D
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E601-E609. PubMed ID: 29317535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response.
    Fink K; Martin L; Mukawera E; Chartier S; De Deken X; Brochiero E; Miot F; Grandvaux N
    Cell Res; 2013 May; 23(5):673-90. PubMed ID: 23545780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Simplex Virus Type 2 Inhibits Type I IFN Signaling Mediated by the Novel E3 Ubiquitin Protein Ligase Activity of Viral Protein ICP22.
    Zhang M; Fu M; Li M; Hu H; Gong S; Hu Q
    J Immunol; 2020 Sep; 205(5):1281-1292. PubMed ID: 32699158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.
    Van Winkle JA; Constant DA; Li L; Nice TJ
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression regulation of zebrafish interferon regulatory factor 9 by promoter analysis.
    Shi J; Zhang YB; Zhang JS; Gui JF
    Dev Comp Immunol; 2013 Dec; 41(4):534-43. PubMed ID: 23916490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9.
    Zhang R; Fang L; Wang D; Cai K; Zhang H; Xie L; Li Y; Chen H; Xiao S
    Virology; 2015 Nov; 485():414-21. PubMed ID: 26342467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
    Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
    Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.
    Parisien JP; Lau JF; Rodriguez JJ; Sullivan BM; Moscona A; Parks GD; Lamb RA; Horvath CM
    Virology; 2001 May; 283(2):230-9. PubMed ID: 11336548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of IRF9 and STAT2 synergistically up-regulates IFN and PKR transcription in Ctenopharyngodon idella.
    Wu Z; Wang L; Xu X; Lin G; Mao H; Ran X; Zhang T; Huang K; Wang H; Huang Q; Xu Q; Hu C
    Mol Immunol; 2017 May; 85():273-282. PubMed ID: 28347954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.
    Hakim MS; Chen S; Ding S; Yin Y; Ikram A; Ma XX; Wang W; Peppelenbosch MP; Pan Q
    Sci Rep; 2018 May; 8(1):8341. PubMed ID: 29844362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs sheds light on interferon signaling in teleosts.
    Sobhkhez M; Skjesol A; Thomassen E; Tollersrud LG; Iliev DB; Sun B; Robertsen B; Jørgensen JB
    FEBS Open Bio; 2014; 4():858-71. PubMed ID: 25379383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling.
    Maiwald T; Schneider A; Busch H; Sahle S; Gretz N; Weiss TS; Kummer U; Klingmüller U
    FEBS J; 2010 Nov; 277(22):4741-54. PubMed ID: 20964804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lack of either IRF9, or STAT2, has surprisingly little effect on human natural killer cell development and function.
    Calvo-Apalategi A; Nevado ML; Bravo-Gallego LY; González-Granado LI; Allende LM; Pena RR; López-Granados E; Reyburn HT
    Immunology; 2024 Jul; 172(3):440-450. PubMed ID: 38514903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.